These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 201222)

  • 1. Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors.
    Schmidt MJ; Thornberry JF
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):42-51. PubMed ID: 201222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of amine depletion by nisoxetine in comparison to other uptake inhibitors.
    Fuller RW; Snoddy HD; Molloy BB
    Psychopharmacol Commun; 1975; 1(5):455-64. PubMed ID: 1228825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 3-(p-trifluoromethylphenoxy). N. N. methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine.
    Fuller RW; Perry KW; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):793-803. PubMed ID: 1151729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system.
    Mishra R; Sulser F
    Commun Psychopharmacol; 1978; 2(4):365-9. PubMed ID: 310378
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical effects in rats after acute and long-term treatment with clovoxamine.
    Bradford LD; Tulp MT; Schipper J
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):188-202. PubMed ID: 2820327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine.
    Mishra R; Janowsky A; Sulser F
    Eur J Pharmacol; 1979 Dec; 60(4):379-82. PubMed ID: 316774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of serotonin reuptake.
    Fuller RW; Wong DT
    Fed Proc; 1977 Jul; 36(8):2154-8. PubMed ID: 326579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine.
    Fuller RW; Perry KW; Molloy BB
    Eur J Pharmacol; 1975 Aug; 33(1):119-24. PubMed ID: 126166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor.
    Perrone MH; Luttinger D; Hamel LT; Fritz PM; Ferraino R; Haubrich DR
    J Pharmacol Exp Ther; 1990 Aug; 254(2):476-83. PubMed ID: 1974638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of alpha-1 adrenergic receptor density and functional responsiveness in rat brain.
    Johnson RD; Iuvone PM; Minneman KP
    J Pharmacol Exp Ther; 1987 Sep; 242(3):842-9. PubMed ID: 2821227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of repeated restraint stress, desmethylimipramine or adrenocorticotropin on the alpha and beta adrenergic components of the cyclic AMP response to norepinephrine in rat brain slices.
    Stone EA; Platt JE; Herrera AS; Kirk KL
    J Pharmacol Exp Ther; 1986 Jun; 237(3):702-7. PubMed ID: 3012065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of pineal noradrenaline concentration in rats by desipramine but not fluoxetine: implications concerning the specificity of these uptake inhibitors.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1977 Nov; 29(11):710-1. PubMed ID: 22613
    [No Abstract]   [Full Text] [Related]  

  • 16. Tryptoline inhibition of serotonin uptake in rat forebrain homogenates.
    Keller KJ; Elliott GR; Holman RB; Vernikos-Danellis J; Barchas JD
    J Pharmacol Exp Ther; 1976 Sep; 198(3):619-25. PubMed ID: 978463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of norepinephrine and 5-hydroxytryptamine reuptake inhibitors on electrically-induced spinal cord seizures in rats.
    Jobe PC; Ray TB
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):185-8. PubMed ID: 6968962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAB receptor modulation of adenylate cyclase activity in rat brain slices.
    Hill DR
    Br J Pharmacol; 1985 Jan; 84(1):249-57. PubMed ID: 2579700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity.
    Ebstein RP; Hermoni M; Belmaker RH
    J Pharmacol Exp Ther; 1980 Apr; 213(1):161-7. PubMed ID: 6244392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.